Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division

Immunology - Tập 107 Số 4 - Trang 452-460 - 2002
Geon Kook Lee1, Hyeon Jin Park1, Megan K. L. MacLeod1, Phillip Chandler1, David H. Munn1, Andrew L. Mellor1
1Program in Molecular Immunology, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA, USA

Tóm tắt

Summary

Cells expressing indoleamine 2,3‐dioxygenase (IDO), an enzyme which catabolizes tryptophan, prevent T‐cell proliferation in vitro, suppress maternal antifetal immunity during pregnancy and inhibit T‐cell‐mediated responses to tumour‐associated antigens. To examine the mechanistic basis of these phenomena we activated naïve murine T cells in chemically defined tryptophan‐free media. Under these conditions T cells expressed CD25 and CD69 and progressed through the first 12 hr of G0/G1 phase but did not express CD71, cyclin D3, cdk4, begin DNA synthesis, or differentiate into cytotoxic effector cells. In addition, activated T cells with their growth arrested by tryptophan deprivation exhibited enhanced tendencies to die via apoptosis when exposed to anti‐Fas antibodies. Apoptosis was inhibited by caspase inhibitor and was not observed when T cells originated from Fas‐deficient mice. These findings suggest that T cells activated in the absence of free tryptophan entered the cell cycle but cell cycle progression ceased in mid‐G1 phase and T cells became susceptible to death via apoptosis, in part though Fas‐mediated signalling. Thus, mature antigen‐presenting cells expressing IDO and Fas‐ligand may induce antigen‐specific T‐cell tolerance by blocking T‐cell cycle progression and by rapid induction of T‐cell activation induced cell death in local tissue microenvironments.

Từ khóa


Tài liệu tham khảo

10.1016/S0952-7915(00)00134-5

10.1016/S0065-2776(08)60404-6

10.1084/jem.183.4.1789

10.1038/32588

10.1016/S0952-7915(00)00133-3

10.4049/jimmunol.166.1.277

10.1084/jem.189.9.1363

10.4049/jimmunol.164.7.3596

10.4049/jimmunol.161.10.5313

10.1126/science.283.5405.1183

10.1126/science.281.5380.1191

10.1038/83183

10.1093/intimm/6.2.277

10.1084/jem.184.4.1573

Zelenika D, 1998, Rejection of H‐Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells, J Immunol, 161, 1868, 10.4049/jimmunol.161.4.1868

10.1093/intimm/8.3.351

10.1084/jem.181.1.127

10.1073/pnas.93.20.11014

10.1073/pnas.96.14.8104

10.1006/bbrc.2000.2565

10.1084/jem.186.5.665

10.1016/S1074-7613(00)80614-7

10.1084/jem.176.1.47

10.1084/jem.191.7.1241

10.1096/fasebj.5.11.1907934

10.1172/JCI118058

10.1016/S0167-5699(99)01520-0

10.2337/diabetes.51.2.356

10.4049/jimmunol.168.8.3771

10.1093/intimm/14.1.65